SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-120107
Filing Date
2016-05-11
Accepted
2016-05-11 16:56:26
Documents
74
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6623_110q.htm 10-Q 628932
2 EX-31.1 a16-6623_1ex31d1.htm EX-31.1 10417
3 EX-31.2 a16-6623_1ex31d2.htm EX-31.2 10431
4 EX-32.1 a16-6623_1ex32d1.htm EX-32.1 5488
5 EX-32.2 a16-6623_1ex32d2.htm EX-32.2 6392
  Complete submission text file 0001104659-16-120107.txt   4150356

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20160331.xml EX-101.INS 749087
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20160331.xsd EX-101.SCH 54309
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20160331_cal.xml EX-101.CAL 39908
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20160331_def.xml EX-101.DEF 194737
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20160331_lab.xml EX-101.LAB 425237
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20160331_pre.xml EX-101.PRE 354751
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 161640542
SIC: 2834 Pharmaceutical Preparations